A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 675, Issue 1-2, 2009, Pages 60-65

  De Feo, Emma ^a   Persiani, Roberto ^a   La Greca, Antonio ^a   Amore, Rosarita ^a   Arzani, Dario ^a   Rausei, Stefano ^a   D'Ugo, Domenico ^a   Magistrelli, Paolo ^a   van Duijn, Cornelia M ^b   Ricciardi, Gualtiero ^a   Boccia, Stefania ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Gastric cancer; Genetic epidemiology; Haplotype; p53; p73; Single nucleotide polymorphisms

Indexed keywords

PROTEIN P53; PROTEIN P73;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CELL CYCLE REGULATION; CONTROLLED STUDY; EXON; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INHERITANCE; INTRON; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; WILD TYPE;

AGED; ALLELES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTRONS; ITALY; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 64249166426     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.02.009     Document Type: Article

References (38)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Zhou Y., Li N., Zhuang W., Liu G.J., Wu T.X., Yao X., Du L., Wei M.L., and Wu X.T. P53 Codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int. J. Cancer 121 (2007) 1481-1486
3. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., and Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 (1997) 809-819
4. Niwa Y., Hamajima N., Atsuta Y., Yamamoto K., Tamakoshi A., Saito T., Hirose K., Nakanishi T., Nawa A., Kuzuya K., and Tajima K. Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett. 205 (2004) 55-60
5. Marabese M., Vikhanskaya F., and Broggini M. p73: a chiaroscuro gene in cancer. Eur. J. Cancer 43 (2007) 1361-1372
6. Pilozzi E., Talerico C., Platt A., Fidler C., and Ruco L. p73 Gene mutations in gastric adenocarcinomas. Mol. Pathol. 56 (2003) 60-62
7. Schabath M.B., Wu X., Wei Q., Li G., Gu J., and Spitz M.R. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 158-161
8. Toyama T., Zhang Z., Nishio M., Hamaguchi M., Kondo N., Iwase H., Iwata H., Takahashi S., Yamashita H., and Fujii Y. Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Res. 9 (2007) R34
9. Wu X., Zhao H., Amos C.I., Shete S., Makan N., Hong W.K., Kadlubar F.F., and Spitz M.R. p53 Genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J. Natl. Cancer Inst. 94 (2002) 681-690
10. Wang-Gohrke S., Weikel W., Risch H., Vesprini D., Abrahamson J., Lerman C., Godwin A., Moslehi R., Olipade O., Brunet J.S., Stickeler E., Kieback D.G., Kreienberg R., Weber B., Narod S.A., and Runnebaum I.B. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br. J. Cancer 81 (1999) 179-183
11. Sprague B.L., Trentham-Dietz A., Garcia-Closas M., Newcomb P.A., Titus-Ernstoff L., Hampton J.M., Chanock S.J., Haines J.L., and Egan K.M. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis 28 (2007) 1680-1686
12. Peller S., Halevy A., Slutzki S., Kopilova Y., and Rotter V. p53 Mutations in matched primary and metastatic human tumors. Mol. Carcinog. 13 (1995) 166-172
13. Li G., Wang L.E., Chamberlain R.M., Amos C.I., Spitz M.R., and Wei Q. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 64 (2004) 6863-6866
14. Hamajima N., Matsuo K., Suzuki T., Nakamura T., Matsuura A., Hatooka S., Shinoda M., Kodera Y., Yamamura Y., Hirai T., Kato T., and Tajima K. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 181 (2002) 81-85
15. Choi J.E., Kang H.G., Chae M.H., Kim E.J., Lee W.K., Cha S.I., Kim C.H., Jung T.H., and Park J.Y. No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population. Biochem. Genet. 44 (2006) 543-550
16. Wang Y.C., Chen C.Y., Chen S.K., Chang Y.Y., and Lin P. p53 Codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin. Cancer Res. 5 (1999) 129-134
17. Starinsky S., Figer A., Ben-Asher E., Geva R., Flex D., Fidder H.H., Zidan J., Lancet D., and Friedman E. Genotype phenotype correlations in Israeli colorectal cancer patients. Int. J. Cancer 114 (2005) 58-73
18. Sullivan A., Syed N., Gasco M., Bergamaschi D., Trigiante G., Attard M., Hiller L., Farrell P.J., Smith P., Lu X., and Crook T. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23 (2004) 3328-3337
19. Pfeifer D., Arbman G., and Sun X.F. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcinogenesis 26 (2005) 103-107
20. Boccia S., Gianfagna F., Persiani R., La Greca A., Arzani D., Rausei S., D'ugo D., Magistrelli P., Villari P., Van Duijn C.M., and Ricciardi G. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers 12 (2007) 635-644
21. Boccia S., Sayed-Tabatabaei F.A., Persiani R., Gianfagna F., Rausei S., Arzani D., La Greca A., D'Ugo D., La Torre G., van Duijn C.M., and Ricciardi G. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 7 (2007) 206
22. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64 (1965) 31-49
23. In: Sobin L.H., and Wittekind C. (Eds). TNM Classification of Malignant Tumors. fifth ed. (1997), Wiley-Liss, New York
24. In: Terwilliger J., and Ott J. (Eds). Handbook of Human Genetic Linkage (1994), John Hopkins University Press, Baltimore
25. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
26. Rothman K.J., et al. Modern Epidemiology (2008), Williams & Wilkins, Lippincott
27. Mitra S., Sikdar N., Misra C., Gupta S., Paul R.R., Roy B., Panda C.K., and Roychoudhury S. Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern Idia. Int. J. Cancer 117 (2005) 786-793
28. Buyru N., Altinisik J., Demokan S., and Dalay N. p53 Genotypes and haplotypes associated with risk of breast cancer. Cancer Detect. Prev. 31 3 (2007) 207-213
29. Ioannidis J.P.A. Meta-analysis in public health: potential and problems. Ital. J. Public Health 3 (2006) 9-14
30. Li G., Sturgis E.M., Wang L.E., Chamberlain R.M., Amos C.I., Spitz M.R., El-Naggar A.K., Hong W.K., and Wei Q. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 25 (2004) 1911-1916
31. Ryan B.M., McManus R., Daly J.S., Carton E., Keeling P.W., Reynolds J.V., and Kelleher D. A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br. J. Cancer 85 (2001) 1499-1503
32. Hu Z., Miao X., Ma H., Tan W., Wang X., Lu D., Wei Q., Lin D., and Shen H. Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int. J. Cancer 114 (2005) 455-460
33. Hiraki A., Matsuo K., Hamajima N., Ito H., Hatooka S., Suyama M., Mitsudomi T., and Tajima K. Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pac. J. Cancer Prev. 4 (2003) 107-112
34. Huang X.E., Hamajima N., Katsuda N., Matsuo K., Hirose K., Mizutani M., Iwata H., Miura S., Xiang J., Tokudome S., and Tajima K. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 10 (2003) 307-311
35. Li H., Yao L., Ouyang T., Li J., Wang T., Fan Z., Fan T., Dong B., Lin B., Li J., and Xie Y. Association of p73 G4C14-to-A4T14 [GC/AT] polymorphism with breast cancer survival. Carcinogenesis 28 (2007) 372-377
36. Ge H., Wang Y.M., Cao Y.Y., Chen Z.F., Wen D.G., Guo W., Wang N., Zhang X.F., Li Y., and Zhang J.H. The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China. Dis. Esophagus 20 (2007) 290-296
37. Singh V., Rastogi N., Mathur N., Singh K., and Singh M.P. Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women. Ann. Epidemiol. 18 (2008) 48-57
38. Kochethu G., Delgado J., Pepper C., Starczynski J., Hooper L., Krishnan S., Fegan C., and Pratt G. Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia. Leuk. Res. 30 (2006) 1113-1118